Institutional Manager · CIK 0001964437
Saturn V Capital Management LP
AUSTIN, TX · File #028-22863
Latest AUM
$544.9M
Positions
20
Top-10 Concentration
76.5%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | ALUMIS INC | ALMS | +3,135,953 | +$30.6M | $0 |
| REDUCE | COGENT BIOSCIENCES INC | COGT | -807,977 | -$28.7M | +$42.8M |
| EXITED | CG ONCOLOGY INC | 156944100 | -579,895 | -$23.4M | $0 |
| NEW | X4 PHARMACEUTICALS INC | XFOR | +5,800,530 | +$23.2M | $0 |
| REDUCE | ABIVAX SA | AAVXF | -152,045 | -$20.5M | +$40.0M |
| EXITED | XENON PHARMACEUTICALS INC | 98420N105 | -503,701 | -$20.2M | $0 |
| NEW | INVIVYD INC | IVVD | +7,735,386 | +$19.1M | $0 |
| EXITED | MERUS N V | N5749R100 | -184,135 | -$17.3M | $0 |
| REDUCE | DYNE THERAPEUTICS INC | DYN | -885,853 | -$17.3M | +$18.5M |
| EXITED | LENZ THERAPEUTICS INC | 52635N103 | -368,176 | -$17.1M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202520 pos · $544.9M
- 13F HOLDINGS REPORTQ/E Sep 202517 pos · $456.0M
- 13F HOLDINGS REPORTQ/E Jun 202524 pos · $246.8M
- 13F HOLDINGS REPORTQ/E Mar 202521 pos · $198.2M
- 13F HOLDINGS REPORTQ/E Dec 202424 pos · $255.4M
- 13F HOLDINGS REPORTQ/E Sep 202425 pos · $279.8M
- 13F HOLDINGS REPORTQ/E Jun 202426 pos · $264.6M
- 13F HOLDINGS REPORTQ/E Mar 202421 pos · $249.4M
- 13F HOLDINGS REPORTQ/E Dec 202320 pos · $238.9M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 649,179 | $87.5M | 16.07% |
| 2 | AMYLYX PHARMACEUTICALS INC | AMLX | 4,496,487 | $54.3M | 9.97% |
| 3 | COGENT BIOSCIENCES INC | COGT | 1,217,064 | $43.2M | 7.93% |
| 4 | JAZZ PHARMACEUTICALS PLC | JAZZ | 248,070 | $42.2M | 7.74% |
| 5 | VAXCYTE INC | PCVX | 798,940 | $36.9M | 6.77% |
| 6 | DYNE THERAPEUTICS INC | DYN | 1,788,616 | $35.0M | 6.42% |
| 7 | PHARVARIS N V | PHVS | 1,140,033 | $31.6M | 5.81% |
| 8 | CELCUITY INC | CELC | 317,095 | $31.6M | 5.80% |
| 9 | ALUMIS INC | ALMS | 3,135,953 | $30.6M | 5.62% |
| 10 | DISC MEDICINE INC | IRON | 298,429 | $23.7M | 4.35% |
| 11 | X4 PHARMACEUTICALS INC | XFOR | 5,800,530 | $23.2M | 4.26% |
| 12 | MONOPAR THERAPEUTICS INC | MNPR | 325,701 | $21.3M | 3.90% |
| 13 | INVIVYD INC | IVVD | 7,735,386 | $19.1M | 3.51% |
| 14 | OCULAR THERAPEUTIX INC | OCUL | 1,504,880 | $18.3M | 3.35% |
| 15 | IMMIX BIOPHARMA INC | IMMX | 2,999,169 | $15.7M | 2.88% |
| 16 | OCULIS HOLDING AG | OCSAW | 516,761 | $10.3M | 1.89% |
| 17 | INHIBIKASE THERAPEUTICS INC | IKT | 3,856,799 | $7.9M | 1.45% |
| 18 | CENTESSA PHARMACEUTICALS PLC | CNTA | 282,692 | $7.1M | 1.30% |
| 19 | OVID THERAPEUTICS INC | OVID | 2,500,000 | $4.1M | 0.75% |
| 20 | INVENTIVA SA | IVEVF | 283,166 | $1.3M | 0.24% |